The content on this website is intended for healthcare professionals and is not intented to be professional medical advice. The Instructions for Use (IFU) for the product must therefore be consulted before use of any product. Please be aware that the product and/or an indication might not be approved in your country, e.g. US. Please contact your Bentley representative for further information.

Close
February 27, 2024

In front of the Bentley headquarters: (from left to right) Martin Dürrstein (CEO of Dürr Dental SE); Dr. Tania Fuchs (Deputy Head of Division Healthcare Industry, Chemistry and Materials), Bentley CEO Sebastian Büchert; Minister of Economic Affairs Dr. Hoffmeister-Kraut; Mayor of Hechingen Philipp Hahn; Lukas Derad (R&D), Cindy Holmberg (Member of Parliament from Bündnis 90/DieGrünen), Kevin Wiktor (R&D) and Bentley CTO Christian Bader. Photo: Bentley

Whistle-stop visit at Bentley: Minister of Economic Affairs Dr. Hoffmeister-Kraut on site in the Medical Valley

The Minister for Economic Affairs, Labor and Tourism visited the Hechingen-based medical technology company Bentley with a delegation of several members of state parliament and Hechingen’s Mayor Philipp Hahn. There were plenty of topics to talk about.

 

Last Friday, Bentley CEO Sebastian Büchert and CTO Christian Bader welcomed Dr. Hoffmeister-Kraut, Baden-Württemberg’s Minister for Economic Affairs, Labor and Tourism, to a dialogue at the European market leader for covered stents in Hechingen’s Lotzenäcker district. In addition to Manuel Hailfinger (CDU), member of the state parliament and member of the Committee on Economic Affairs, Labor and Tourism as well as the Committee on the Environment, Climate and Energy, Cindy Holmberg, member of state parliament for the Hechingen-Münsingen constituency from Bündnis 90/Die Grünen, took part in the exchange across party lines. Mayor Philipp Hahn also took the opportunity to participate in the exchange between politics, business and science in his municipality located in the heart of the Medical Valley.

At the center of the open discussions were the current issues and challenges facing medical technology production at the Hechingen site, with a focus on the changing political and regulatory framework related to planned EU legislative measures. The potential impact on the production of necessary precursors and the risks to the European supply chain were intensly debated. This included an emphasis on the importance of limiting geostrategic dependencies on countries such as China to maintain long-term competitiveness. All agreed that bureaucracy and reporting requirements have already caused excessive costs and represent a significant constraint that needs to be reduced in a joint effort in the near future. This is why an exchange between policymakers, associations, science and the business sector is so important.

Christian Bader, Bentley’s chief technology officer, pointed out that predictability is critical for investments of all kinds in an industry where time frames of seven to ten years from the initial idea to product approval are the norm.


Dr. Hoffmeister-Kraut emphasized: “Having a direct exchange with companies in the region is particularly important to me given today’s very challenging environment for many areas of the manufacturing industry. Nothing is more valuable than a face-to-face conversation and getting a first-hand impression on the ground. A predictable regulatory framework and reliable supply chains are essential, especially for dynamically growing medical technology companies like Bentley who are planning for the long term. Especially the medical device industry suffers from regulatory requirements and further increase of bureaucracy. I will not cease to promote better framework conditions in Brussels and Berlin.”

 

About Bentley  
Founded in 2009 by Lars Sunnanväder and Miko Obradovic and based in the medical technology stronghold of Hechingen in Baden-Württemberg, Bentley InnoMed GmbH develops, produces and distributes implants and catheters for the endovascular treatment of peripheral vascular diseases and diseases in the area of the aorta. The company has since developed into one of the world’s leading manufacturers and European market leader for covered stents. Today, more than 400 employees work for Bentley Endovascular Group AB in a strong culture of innovation. Bentley is one of the most important employers in the county of Zollernalb and beyond. The company generated revenues of EUR 69 million in the 2022 financial year and is on a dynamic growth trajectory with its product innovations and the development of new markets.

 

Contact for further information
Stephan Haas, Corporate Communications, +49 7471 98499 5691, s.haas@bentley.global

International

Customer service:
+49 7471 984 995 10

Contact

Bentley InnoMed GmbH

Lotzenäcker 3
72379 Hechingen / Germany
+49 7471 99 99-0

info@bentley.global

www.bentley.global

United States

Customer service:
+1 770 295 2288

Contact

Bentley US Inc.

2220 Northmont Pkwy. Suite 250
Duluth, GA 30096 / USA
+1 770 295 2288

info@bentley.global

www.bentley.global